Difference between revisions of "Toltrazuril5:"
(→Dose:) |
(→Dose:) |
||
Line 22: | Line 22: | ||
https://www.vgr1.com/toltrazuril/ dosage calculator | |||
==Indications:== | ==Indications:== |
Revision as of 18:47, 30 March 2023
Treatment for Coccidia infestation, Toltrazuril (Baycox) should be used in more advanced cases as it will completely eradicate the parasites'.
Symptoms of Coccidia are:
- Depression
- Anorexia
- Anemia
- Signs of pain such as hunching
- Pale mucous membranes
- Blood or mucous in the feces
- Poor coat condition
- Dehydration
- Weight loss or poor weight gainor growth
- In severe cases of intestinal coccidiosis intussusception, convulsions or paralysis or fatality may occur
- In severe cases of hepatic coccidiosis weakness, liver damage, and bile duct damage may occur, followed by coma
Drug class:
Dose:
Dosage is 20mg/kg. Concentration is 5% or 50mg / mL which is equivalent to approximately .18ml/cc per pound.
https://www.vgr1.com/toltrazuril/ dosage calculator
Indications:
Side Effects
During Pregnancy or Nursing
Patient Tips
Drug Interactions
Compare Alternatives
Toltrazuril (Baycox) treatment against coccidiosis https://pubmed.ncbi.nlm.nih.gov/25286655/
Evaluation of amprolium and toltrazuril efficacy in controlling natural intestinal rabbit coccidiosis https://pubmed.ncbi.nlm.nih.gov/29163644/
Plasma disposition of toltrazuril and its metabolites, toltrazuril sulfoxide and toltrazuril sulfone, in rabbits after oral administration https://pubmed.ncbi.nlm.nih.gov/20083354/
Eimeria stiedae: experimental infection in rabbits and the effect of treatment with toltrazuril and ivermectin
https://pubmed.ncbi.nlm.nih.gov/18321485/
Pharmacokinetics of toltrazuril and its metabolites after oral and parenteral administration of novel oil-based suspension based on micro-environmental pH-modifying solid dispersion in rabbits https://pubmed.ncbi.nlm.nih.gov/34597913/
Toltrazuril mixed nanomicelle delivery system based on sodium deoxycholate-Brij C20 polyethylene ether-triton x100: Characterization, solubility, and bioavailability study https://pubmed.ncbi.nlm.nih.gov/29289823/
Comparison of toltrazuril and sulphadimethoxine in the treatment of intestinal coccidiosis in pet rabbits https://pubmed.ncbi.nlm.nih.gov/20729515/
The production and characterisation of an antibody to detect the coccidiostat toltrazuril and its metabolite ponazuril https://pubmed.ncbi.nlm.nih.gov/12790197/
Pharmacokinetics and improved bioavailability of toltrazuril after oral administration to rabbits https://pubmed.ncbi.nlm.nih.gov/20860101/
Herbal formulations as feed additives in the course of rabbit subclinical coccidiosis https://pubmed.ncbi.nlm.nih.gov/24930248/